Abstract:A dual-response (near-infrared, alternating magnetic field) multifunctional nanoplatform was developed based on urokinase plasminogen activators (uPA)-loaded metal–organic-framework (MOF)-derived carbon nanomaterials (referred to below) for thrombolytic therapy. uPA loaded in mesoporous CFs could be released under the action of near-infrared (NIR)-mediated photothermy to achieve superficial thrombolysis. More importantly, with the assistance of alternating magnetic field (AMF), this system could also precisely heat the thrombosis in the deep tissue area. Quantitative experiments proved that the thrombolytic efficiency of this dual-response system at deep venous thrombosis was nearly 6 times than that of NIR alone. This is the first application that MOF-derived carbon nanomaterials in the field of targeted thrombolysis. To our delight, the MOF-derived carbon nanomaterials (CFs) not only maintained the drug-carrying capacity, but also endowed CFs with reliable magnetic targeting ability. More encouragingly, the CFs also showed extraordinary angiogenic performance, thus opening up the prospect of its clinical application.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c03134?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c03134</a>.Particle size distribution of CFs (Figure S1a). Stability of the CFs hydrodynamic size during different incubation periods with serum (Figure S1b). High-resolution XPS spectra of (a) Fe 2p, (b) O 1s, and (c) C 1s (Figure S2). The summary of nitrogen adsorption–desorption analysis of MOFs (Fe) and CFs samples (Table S1). Pore size distribution of (a) MOFs (Fe) and (b) CFs samples (Figure S3). VSM curve of at room temperature (Figure S4). The photothermal effect and magnetothermal effect of CFs (Figure S5). uPA release from after being placed in saline over 7 days (Figure S6). The thickness of pork (Figure S7a). Deep evaluation of the magnetic field attracting CFs using different thickness of pork (scale bar = 1 cm) (Figure S7b). SEM analysis of thrombolysis (scale bar = 2 μm) (Figure S8). Scanning electron microscopy (SEM) images and the elemental mapping data of the degradation of CFs at the thrombus site at (a) 20 min, (b) 40 min, and (c) 1 h (scale bar = 5 μm) (Figure S9). SEM images of RBCs treated with different concentrations of CFs (scale bar = 5 μm) (Figure S10). Cell viability of HSF and HUVECs treated with different concentrations of CFs for 24 h (Figure S11a). Cell viability with various concentrations of CFs, CFs + NIR, CFs + AMF for 12 and 48 h (Figure S11b). Cell viability of HUVECs cocultured with different concentrations of CFs and VEGF for various time as indicated above. (Error bars represent the standard deviation of six separate measurements) (Figure S12). Photos (clots are marked in blue circles, scale bar = 1 cm) of clots before and after treatment for 24 h (Figure S13). The amount of Fe in the major organs and blood after treatment for 7 days (Figure S14). Four indicators of coagulation in SD rats (Figure S15a). Some indexes of liver and kidney function in SD rats (Figure S15b). The average body weight of rats in each group during the treatment periods (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c03134/suppl_file/am1c03134_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis (Small 11/2023)

Gold-iron oxide nanoparticle: A unique multimodal theranostic approach for thrombosis

Plasma‐Derived Nanoclusters for Site‐Specific Multimodality Photo/Magnetic Thrombus Theranostics

Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles

Near-Infrared-Light-Responsive Copper Oxide Nanoparticles As Efficient Theranostic Nanoagents for Photothermal Tumor Ablation

Effect of the Size and Shape of Dendronized Iron Oxide Nanoparticles Bearing a Targeting Ligand on MRI, Magnetic Hyperthermia, and Photothermia Properties—From Suspension to In Vitro Studies

A Biomimicking and Multiarm Self‐Indicating Nanoassembly for Site‐Specific Photothermal‐Potentiated Thrombolysis Assessed in Microfluidic and in vivo Models

Shear Stress‐Triggered Theranostic Nanoparticles for Piezoelectric‐Fenton‐Photodynamic Thrombolysis and Endogenous Thrombus Imaging

Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation

Intraparticle Molecular Orbital Engineering of Semiconducting Polymer Nanoparticles As Amplified Theranostics for in Vivo Photoacoustic Imaging and Photothermal Therapy.

Advancements in Iron Oxide Nanoparticles for Multimodal Imaging and Tumor Theranostics

Aggregation Induced Emission Fluorogens Based Nanotheranostics for Targeted and Imaging-Guided Chemo-Photothermal Combination Therapy

Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging

A Silver‐Induced Absorption Red‐Shifted Dual‐Targeted Nanodiagnosis‐Treatment Agent for NIR‐II Photoacoustic Imaging‐Guided Photothermal and ROS Simultaneously Enhanced Immune Checkpoint Blockade Antitumor Therapy

Phototheranostic nanoparticles with aggregation-induced emission as a four-modal imaging platform for image-guided photothermal therapy and ferroptosis of tumor cells

Peptide-Directed Hierarchical Mineralized Silver Nanocages for Anti-Tumor Photothermal Therapy

Activatable Near Infrared Dye Conjugated Hyaluronic Acid Based Nanoparticles As a Targeted Theranostic Agent for Enhanced Fluorescence/ct/photoacoustic Imaging Guided Photothermal Therapy

Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent

A Small-Molecule Based Organic Nanoparticle for Photothermal Therapy and Near-Infrared-IIb Imaging

Target-responsive DNA Aptamer-Conjugated Superparamagnetic Ag/CuS Nanoparticles As Near-Infrared Light-Triggered Theranostics and Dual-Modal Imaging

Targeted Thrombolytic Therapy with Metal–Organic-Framework-Derived Carbon Based Platforms with Multimodal Capabilities